Anti HIV-1 agents 5: Synthesis and anti-HIV-1 activity of some N-arylsulfonyl-3-acetylindoles in vitro

被引：35
|
作者：
Ran, Jun-Qiang [1 ]
Huang, Ning [2 ]
Xu, Hui [1 ]
Yang, Liu-Meng [2 ]
Lv, Min [1 ]
Zheng, Yong-Tang [2 ]
机构：
[1] NW A&F Univ, Coll Sci, Lab Pharmaceut Design & Synth, Yangling 712100, Peoples R China
[2] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech Chinese Acad, Kunming 650223, Peoples R China
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 12期
关键词：
N-Arylsulfonyl-3-acetylindole; Acquired immune-deficiency syndrome; Human immunodeficiency virus-1; Inhibitor;
D O I：
10.1016/j.bmcl.2010.04.132
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
In continuation of our program aimed at the discovery and development of compounds with superior anti-human immunodeficiency virus type 1 (HIV-1) activity, 21N-arylsulfonyl-3-acetylindole analogs (2a-u) were synthesized and preliminarily evaluated as HIV-1 inhibitors in vitro. Among of all the analogs, several compounds exhibited significant anti-HIV-1 activity, especially N-phenylsulfonyl-3-acetyl-6-methylindole (2j) and N-(p-ethyl)phenylsulfonyl-3-acetyl-6-methylindole (2n) showed the most potent anti-HIV-1 activity with EC50 values of 0.36 and 0.13 mu g/mL, and TI values of >555.55 and 791.85, respectively. It demonstrated that introduction of the acetyl group at the 3-position of N-arylsulfonyl-6-methylindoles could generally lead to the more potent analogs. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码：3534 / 3536
页数：3
相关论文
共 50 条
  • [21] Design, Synthesis and Anti-HIV-1 Activity of Modified Styrylquinolines
    Mahajan, Shivani
    Gupta, Shiv
    Jariwala, Nisha
    Bhadane, Deepali
    Bhutani, Late K. K.
    Kulkarni, Smita
    Singh, Inder Pal
    LETTERS IN DRUG DESIGN & DISCOVERY, 2018, 15 (09) : 937 - 944
  • [22] SYNTHESIS AND ANTI-HIV-1 ACTIVITY OF THIO ANALOGS OF DIHYDROALKOXYBENZYLOXOPYRIMIDINES
    MAI, A
    ARTICO, M
    SBARDELLA, G
    MASSA, S
    LOI, AG
    TRAMONTANO, E
    SCANO, P
    LACOLLA, P
    JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (17) : 3258 - 3263
  • [23] Interactions of HIV-1 proteins as targets for developing anti-HIV-1 peptides
    Chandra, Koushik
    Maes, Michal
    Friedler, Assaf
    FUTURE MEDICINAL CHEMISTRY, 2015, 7 (08) : 1055 - 1077
  • [24] Synthesis of New Pyridazine Derivatives as Potential Anti-HIV-1 Agents
    Ferro, Stefania
    Agnello, Stefano
    Barreca, Maria Letizia
    De Luca, Laura
    Christ, Frauke
    Gitto, Rosaria
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2009, 46 (06) : 1420 - 1424
  • [25] Anti-HIV-1 activity of inorganic polyphosphates
    Lorenz, B
    Leuck, J
    Kohl, D
    Muller, WEG
    Schroder, HC
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1997, 14 (02): : 110 - 118
  • [26] ABASIC OLIGODEOXYRIBONUCLEOSIDE PHOSPHOROTHIOATES - SYNTHESIS AND EVALUATION AS ANTI-HIV-1 AGENTS
    IYER, RP
    UZNANSKI, B
    BOAL, J
    STORM, C
    EGAN, W
    MATSUKURA, M
    BRODER, S
    ZON, G
    WILK, A
    KOZIOLKIEWICZ, M
    STEC, WJ
    NUCLEIC ACIDS RESEARCH, 1990, 18 (10) : 2855 - 2859
  • [27] The anti-HIV-1 activity associated with saliva
    Shine, N
    Konopka, K
    Duzgunes, N
    JOURNAL OF DENTAL RESEARCH, 1997, 76 (02) : 634 - 640
  • [28] ANTI-HIV-1 ACTIVITY OF CURDLAN SULFATE
    AOKI, T
    KANEKO, Y
    TING, RCY
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1993, 6 (06): : 675 - 675
  • [29] Anti-HIV-1 activity of benzothiadiazine dioxide
    Martinez, A
    Gil, C
    Castro, A
    Perez, C
    Witvrouw, M
    Pannecouque, C
    Balzarini, J
    De Clercq, E
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 2001, 12 (06): : 347 - 351
  • [30] Anti-HIV-1 activity of herbs in Labiatae
    Yamasaki, K
    Nakano, M
    Kawahata, T
    Mori, H
    Otake, T
    Ueba, N
    Oishi, I
    Inami, R
    Yamane, M
    Nakamura, M
    Murata, H
    Nakanishi, T
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1998, 21 (08) : 829 - 833
12345